OR7E126P

Across TCGA pan-cancer cohorts, OR7E126P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated OR7E126P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher OR7E126P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E126P expression acts as an unfavorable survival marker, although some lineages such as UCS and SKCM show a favorable association.

KIRC, ACC, and LIHC are the cancer types where OR7E126P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.424	0.667	.001	123	view →
ACC	DFS	Median	All	0.228	0.672	<.001	94	view →
LIHC	OS	Median	II,III,IV	0.491	0.725	<.001	71	view →
UCS	OS	Quartile	II,III,IV	0.869	0.245	<.001	70	view →
KICH	DFS	Quartile	II,III,IV	0.376	0.932	.003	45	view →
LGG	OS	Median	All	0.367	0.511	<.001	45	view →
SKCM	OS	Quartile	All	0.403	0.275	.008	34	view →
OV	OS	Tertile	All	0.360	0.248	.001	30	view →
BRCA	OS	Tertile	IV	0.885	0.354	.003	26	view →
HNSC	DFS	Median	IV	0.739	0.396	<.001	24	view →
STAD	DFS	Median	III,IV	0.569	0.318	.022	16	view →
READ	DFS	Median	IV	0.365	0.780	.004	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

OR7E126P–KIRC (DFS)

Open the KIRC breakdown →